Allegra Medical Technologies Limited

ASX:AMT Stock Report

Market Cap: AU$3.5m

Allegra Medical Technologies Past Earnings Performance

Past criteria checks 0/6

Allegra Medical Technologies's earnings have been declining at an average annual rate of -24.8%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 30.6% per year.

Key information

-24.8%

Earnings growth rate

-23.0%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate-30.6%
Return on equityn/a
Net Margin480.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Allegra Orthopaedics (ASX:AMT) Is Making Moderate Use Of Debt

Apr 18
Allegra Orthopaedics (ASX:AMT) Is Making Moderate Use Of Debt

Here's Why Allegra Orthopaedics (ASX:AMT) Can Afford Some Debt

Sep 10
Here's Why Allegra Orthopaedics (ASX:AMT) Can Afford Some Debt

What Does Allegra Orthopaedics' (ASX:AMT) CEO Pay Reveal?

Jan 27
What Does Allegra Orthopaedics' (ASX:AMT) CEO Pay Reveal?

We Think Allegra Orthopaedics (ASX:AMT) Can Easily Afford To Drive Business Growth

Dec 05
We Think Allegra Orthopaedics (ASX:AMT) Can Easily Afford To Drive Business Growth

Revenue & Expenses Breakdown
Beta

How Allegra Medical Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:AMT Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23-1-311
30 Sep 230-211
30 Jun 231-211
31 Dec 221-211
30 Sep 221-212
30 Jun 221-212
31 Mar 225-232
31 Dec 215-233
30 Sep 216-132
30 Jun 216-132
31 Mar 216-132
31 Dec 206032
30 Sep 206-132
30 Jun 206-133
31 Mar 206-133
31 Dec 196-133
30 Sep 195-132
30 Jun 195-132
31 Mar 195-132
31 Dec 185-131
30 Sep 185-131
30 Jun 185-131
31 Mar 185031
31 Dec 176031
30 Sep 176031
30 Jun 176131
31 Mar 176031
31 Dec 166-141
30 Sep 166-141
30 Jun 166-241
31 Mar 167-242
31 Dec 157-242
30 Sep 158-142
30 Jun 159-142
31 Mar 159-141
31 Dec 149041
30 Sep 149041
30 Jun 149041
31 Mar 149-141
31 Dec 138-141
30 Sep 138-141
30 Jun 138041

Quality Earnings: AMT is currently unprofitable.

Growing Profit Margin: AMT is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AMT is unprofitable, and losses have increased over the past 5 years at a rate of 24.8% per year.

Accelerating Growth: Unable to compare AMT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AMT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: AMT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.